ABBV-CLS-579
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ABBV-CLS-579, covering 2025-09-25 to 2025-09-25. Get the full timeline:
Most recent: Clinical Trial Update: First In Human Study With ABBV-CLS-579 When Given Alone and In Combination In Participants With Locally Advanced Or Metastatic Tumors [Phase 1]